Top ▲

mitogen-activated protein kinase kinase kinase 11

Click here for help

Target not currently curated in GtoImmuPdb

Target id: 2071

Nomenclature: mitogen-activated protein kinase kinase kinase 11

Abbreviated Name: MLK3

Family: MLK subfamily

Contents:

Gene and Protein Information Click here for help
Species TM AA Chromosomal Location Gene Symbol Gene Name Reference
Human - 847 11q13.1 MAP3K11 mitogen-activated protein kinase kinase kinase 11
Mouse - 850 19 4.34 cM Map3k11 mitogen-activated protein kinase kinase kinase 11
Rat - 850 1q43 Map3k11 mitogen-activated protein kinase kinase kinase 11
Previous and Unofficial Names Click here for help
MEKK11 | mixed lineage kinase 3 | MLK3 | PTK1 | RHOE | SPRK | Src-homology 3 domain-containing proline-rich kinase
Database Links Click here for help
Alphafold Q16584 (Hs), Q80XI6 (Mm), Q66HA1 (Rn)
BRENDA 2.7.11.25
ChEMBL Target CHEMBL2708 (Hs), CHEMBL2434817 (Mm)
Ensembl Gene ENSG00000173327 (Hs), ENSMUSG00000004054 (Mm), ENSRNOG00000020773 (Rn)
Entrez Gene 4296 (Hs), 26403 (Mm), 309168 (Rn)
Human Protein Atlas ENSG00000173327 (Hs)
KEGG Enzyme 2.7.11.25
KEGG Gene hsa:4296 (Hs), mmu:26403 (Mm), rno:309168 (Rn)
OMIM 600050 (Hs)
Pharos Q16584 (Hs)
RefSeq Nucleotide NM_002419 (Hs), NM_022012 (Mm), NM_001013150 (Rn)
RefSeq Protein NP_002410 (Hs), NP_071295 (Mm), NP_001013168 (Rn)
UniProtKB Q16584 (Hs), Q80XI6 (Mm), Q66HA1 (Rn)
Wikipedia MAP3K11 (Hs)
Enzyme Reaction Click here for help
EC Number: 2.7.11.25

Download all structure-activity data for this target as a CSV file go icon to follow link

Inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Action Value Parameter Reference
compound 8 [PMID: 24044867] Small molecule or natural product Primary target of this compound Hs Inhibition 8.5 pIC50 4
⤷ pIC50 8.5 (IC50 3x10-9 M) [4]
CEP-1347 Small molecule or natural product Click here for species-specific activity table Hs Inhibition 7.6 – 8.2 pIC50 4-5
⤷ pIC50 7.6 – 8.2 (IC50 2.3x10-8 – 6x10-9 M) [4-5]
URMC-099 Small molecule or natural product Primary target of this compound Click here for species-specific activity table Hs Inhibition 7.8 pIC50 4
⤷ pIC50 7.8 (IC50 1.4x10-8 M) [4]
Sanofi-14h Small molecule or natural product Click here for species-specific activity table Immunopharmacology Ligand Hs Inhibition 7.1 pIC50 2
⤷ pIC50 7.1 (IC50 8.4x10-8 M) [2]
DiscoveRx KINOMEscan® screen Click here for help
A screen of 72 inhibitors against 456 human kinases. Quantitative data were derived using DiscoveRx KINOMEscan® platform.
http://www.discoverx.com/services/drug-discovery-development-services/kinase-profiling/kinomescan
Reference: 3,6
Key to terms and symbols Click column headers to sort
Target used in screen: MLK3
Ligand Sp. Type Action Value Parameter
tamatinib Small molecule or natural product Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 8.0 pKd
midostaurin Small molecule or natural product Approved drug Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 7.8 pKd
lestaurtinib Small molecule or natural product Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 7.7 pKd
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 7.7 pKd
KW-2449 Small molecule or natural product Hs Inhibitor Inhibition 6.6 pKd
foretinib Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.5 pKd
NVP-TAE684 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.4 pKd
PD-173955 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.3 pKd
tozasertib Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 6.2 pKd
pazopanib Small molecule or natural product Approved drug Hs Inhibitor Inhibition 6.1 pKd
Displaying the top 10 most potent ligands  View all ligands in screen »
EMD Millipore KinaseProfilerTM screen/Reaction Biology Kinase HotspotSM screen Click here for help
A screen profiling 158 kinase inhibitors (Calbiochem Protein Kinase Inhibitor Library I and II, catalogue numbers 539744 and 539745) for their inhibitory activity at 1µM and 10µM against 234 human recombinant kinases using the EMD Millipore KinaseProfilerTM service.

A screen profiling the inhibitory activity of 178 commercially available kinase inhibitors at 0.5µM against a panel of 300 recombinant protein kinases using the Reaction Biology Corporation Kinase HotspotSM platform.

http://www.millipore.com/techpublications/tech1/pf3036
http://www.reactionbiology.com/webapps/main/pages/kinase.aspx

Reference: ...1
Key to terms and symbols Click column headers to sort
Target used in screen: nd/MLK3(MAP3K11)
Ligand Sp. Type Action % Activity remaining at 0.5µM % Activity remaining at 1µM % Activity remaining at 10µM
K-252a Small molecule or natural product Hs Inhibitor Inhibition 0.7
staurosporine Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 1.1
Cdk1/2 inhibitor III Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 1.3
SB 218078 Small molecule or natural product Hs Inhibitor Inhibition 1.4
midostaurin Small molecule or natural product Approved drug Ligand has a PDB structure Immunopharmacology Ligand Hs Inhibitor Inhibition 1.4
Gö 6976 Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 2.2
Cdk2 inhibitor IV Small molecule or natural product Ligand has a PDB structure Hs Inhibitor Inhibition 5.6
JAK3 inhibitor VI Small molecule or natural product Hs Inhibitor Inhibition 8.7
Syk inhibitor Small molecule or natural product Immunopharmacology Ligand Hs Inhibitor Inhibition 9.9
indirubin derivative E804 Small molecule or natural product Hs Inhibitor Inhibition 10.5
Displaying the top 10 most potent ligands  View all ligands in screen »

References

Show »

1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011) Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]

2. Bago R, Sommer E, Castel P, Crafter C, Bailey FP, Shpiro N, Baselga J, Cross D, Eyers PA, Alessi DR. (2016) The hVps34-SGK3 pathway alleviates sustained PI3K/Akt inhibition by stimulating mTORC1 and tumour growth. EMBO J, 35 (17): 1902-22. [PMID:27481935]

3. Davis MI, Hunt JP, Herrgard S, Ciceri P, Wodicka LM, Pallares G, Hocker M, Treiber DK, Zarrinkar PP. (2011) Comprehensive analysis of kinase inhibitor selectivity. Nat Biotechnol, 29 (11): 1046-51. [PMID:22037378]

4. Goodfellow VS, Loweth CJ, Ravula SB, Wiemann T, Nguyen T, Xu Y, Todd DE, Sheppard D, Pollack S, Polesskaya O et al.. (2013) Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3. J Med Chem, 56 (20): 8032-48. [PMID:24044867]

5. Maroney AC, Finn JP, Connors TJ, Durkin JT, Angeles T, Gessner G, Xu Z, Meyer SL, Savage MJ, Greene LA et al.. (2001) Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J Biol Chem, 276 (27): 25302-8. [PMID:11325962]

6. Wodicka LM, Ciceri P, Davis MI, Hunt JP, Floyd M, Salerno S, Hua XH, Ford JM, Armstrong RC, Zarrinkar PP et al.. (2010) Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry. Chem Biol, 17 (11): 1241-9. [PMID:21095574]

How to cite this page

MLK subfamily: mitogen-activated protein kinase kinase kinase 11. Last modified on 04/01/2024. Accessed on 19/04/2024. IUPHAR/BPS Guide to PHARMACOLOGY, https://www.guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=2071.